Latest Articles
'I lost 11st with basic change after I couldn't get on helicopter' - The Mirror
'I lost 11st with basic change after I couldn't get on helicopter' The Mirror
Published: May 2, 2025, 6:03 a.m.
Insights into endometriosis symptom trajectories and assessment of surgical intervention outcomes using longitudinal actigraphy - Nature
Insights into endometriosis symptom trajectories and assessment of surgical intervention outcomes using longitudinal actigraphy Nature
Published: May 2, 2025, 5:38 a.m.
Women with endometriosis at higher risk of immune conditions, study finds - Oxford Mail
Women with endometriosis at higher risk of immune conditions, study finds Oxford Mail
Published: May 2, 2025, 4 a.m.
Women with endometriosis at higher risk of immune conditions, study finds - This Is Oxfordshire
Women with endometriosis at higher risk of immune conditions, study finds This Is Oxfordshire
Published: May 2, 2025, 4 a.m.
Endometriosis Raises Risk of Premature Menopause, Study Finds - Medical Dialogues
Endometriosis Raises Risk of Premature Menopause, Study Finds Medical Dialogues
Published: May 2, 2025, 2:45 a.m.
Watch 9News Latest Stories - Season 2025 - Election leaders make last-ditch scramble for votes across the country - 9Now
Watch 9News Latest Stories - Season 2025 - Election leaders make last-ditch scramble for votes across the country 9Now
Published: May 2, 2025, 2:17 a.m.
Endometriosis linked to premature and early menopause - NZ Doctor
Endometriosis linked to premature and early menopause NZ Doctor
Published: May 2, 2025, 1:09 a.m.
Little-known Endometriosis symptoms as new pill approved on NHS - Daily Express
Little-known Endometriosis symptoms as new pill approved on NHS Daily Express
Published: May 2, 2025, 12:30 a.m.
Endometriosis signs and symptoms as new pill approved for painful condition - Surrey Live
Endometriosis signs and symptoms as new pill approved for painful condition Surrey Live
Published: May 2, 2025, 12:22 a.m.
Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial.
To evaluate the safety and pharmacokinetics/pharmacodynamics of AMY109, an anti-interleukin-8 recycling antibody in a first-in-human phase 1 trial in healthy volunteers (HVs) and patients with endometriosis.
Published: May 2, 2025, midnight
Link copied to clipboard!